Levocetirizin Al (Levocetirizine Dihydrochloride)

Levocetirizine dihydrochloride selectively blocks peripheral H1‑histamine receptors, preventing histamine from binding and triggering the cascade that leads to vasodilation, increased vascular permeability, and nerve stimulation. This inhibition reduces the typical allergic manifestations such as itching, swelling, and mucus production.

The appropriate dose of Levocetirizin Al is determined by a qualified healthcare professional based on the patient’s age, weight, renal function, and clinical response. Prescribers set the regimen according to current clinical guidelines and individual patient needs.

Safety data for levocetirizine during pregnancy and lactation are limited. Healthcare providers should weigh the potential benefits against any possible risks and consider alternative therapies when appropriate. Pregnant or nursing patients should discuss use with their physician.

To request Levocetirizin Al, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Levocetirizin Al is a second‑generation H1‑receptor antagonist, offering effective allergy relief with a lower incidence of sedation compared with first‑generation antihistamines. Its rapid onset and once‑daily dosing make it convenient, while its selectivity reduces many central nervous system side effects seen with older agents.

Levocetirizin Al should be stored at ambient temperature, below 25 °C, in its original packaging. Keep the product away from moisture, direct sunlight, and excessive heat to maintain its stability and potency throughout its shelf life.

Levocetirizin Al is taken orally, usually as a tablet or oral solution, with or without food. Patients should follow the prescribing clinician’s instructions regarding timing and whether to swallow the dose whole or dissolve it, if a liquid formulation is provided.

Although rare, serious adverse reactions can include angioedema, severe skin reactions such as Stevens‑Johnson syndrome, anaphylaxis, thrombocytopenia, and significant liver enzyme elevations. Any signs of swelling, rash, or systemic allergic response require immediate medical attention.

Levocetirizin Al is contraindicated in individuals with known hypersensitivity to levocetirizine, cetirizine, or any excipients in the formulation. Patients with severe renal impairment may need alternative therapy or dose adjustment, and those taking multiple CNS depressants should be evaluated carefully.